Similarly, in a large cohort of 1487 CRC patients by Kothari et al., PIK3CA-mutations did not significantly correlate with cancer-specific survival or overall survival in aspirin users [32]. The gene discussed is PIK3CA; the disease is colorectal carcinoma.